Laura Tadvalkar is a Managing Director at RA Capital Management, L.P., where she invests in life sciences and therapeutics. She focuses on new company creation, seed, early stage, and Series B opportunities across healthcare, including biotechnology, pharmaceuticals, medical devices, diagnostics, research tools, and radiopharmaceuticals, and invests in companies in the United States with a concentration in the Greater Boston/New England region. She serves on the boards of Hemab Therapeutics, Hyku Biosciences, Be Biopharma, Typewriter Therapeutics, Inc., and Cidara Therapeutics, and has invested in companies like Hyku, Expansion Therapeutics, Be Biopharma, Hemab, and Aliada Therapeutics. Before her current role, she was a Principal and a Venture Senior Associate at RA Capital Management, L.P. Laura graduated from Harvard University and lives in Boston, Massachusetts.
Laura Tadvalkar, Managing Director @ RA. Profile with intro opportunities and ranking information.
Not Yet Mapped
We've created a profile for Laura Tadvalkar from RA Capital Management. Our ranking analysis and additional data will be available once our research is complete.
Rankings and detailed information coming soon
Network Strength
No ranking data available yet.
How to get an intro to Laura
Map your path to Laura instantly
Connect your network and Draftboard will automatically find and score the strongest paths to Laura
That's it. Draftboard does the rest.
Rankings based on connection strength analysis - we ONLY show aggregate data, never specific connection data.